Biotek-snakken — Marts 2021
-
STRO- BMS får ODD på BCMA ADC https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=802520
-
– Orphazyme has upcoming catalysts for the stock in the first half of the year, Bank of America analysts said, reiterating their buy rating.
• Price target unchanged
• Orphazyme has a first-in-class heat shock protein approach in areas of high under-met needs: BofA
• Catalysts are ALS & IBM readouts (in the first half of the year) and NPC June 17 -
Og Danske fastholder Buy efter regnskab - target uændret 165
-
@sukkeralf - er du fortsat afventende i markedet eller ved at tage udvalgte positioner?
-
@fandel - velbekomme - men den er godt nok tung
-
Det var et skriv om forskellige CD47. https://drive.google.com/file/d/1izk0BFPtslVRCsui3VzElU2lTNqrA16p/view
-
jeps - så nervøst indtil da:)
-
Takker...sikke spydig du er i dag
Er du nu også sur på alt og alle pga. nedgangen i Genmab...haha Til info skrev jeg "Trillium", og der kom ingenting frem (så hørte min tålmodighed op). Men takker. Aktien er nu halveret fra toppen...køber lidt ekstra hvis vi skal længere ned. Har du selv en position? -
har du prøvet at skrive "tril" i det lille felt til venstre for søg knappen. Det er nok et godt køb. Undskyld jeg griner Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind